Phacilitate Leaders Forum

Phacilitate Leaders Europe Agenda 2018


Panel discussion: How do you design viral vectors to provide a safe, life time cure for gene therapy delivery to patients with monogenic diseases and beyond?

Getting technical - Cell & Gene Therapy Europe
Have your say: panel discussion to be opened up to the audience for input after each discussion point
Amit Nathwani, CSO - Freeline Therapeutics
Sven Kili, Principle - Sven Kili Consulting Ltd
Uta Griesenbach, Professor, Molecular Medicine, National Heart and Lung Institute - Imperial College London
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd